The identification of multipotent adipose-derived stromal cells (ASC) has raised hope that
tissue regeneration approaches established with bone-marrow-derived stromal cells …

The osteogenic and chondrogenic differentiation ability of adipose-derived mesenchymal
stromal cells (ASCs) and their potential therapeutic applications in bone and cartilage …

As the average age of the population grows, the incidence of osteoporosis and skeletal
diseases continues to rise. Current treatment options for skeletal repair include …

The possibility of using adipose tissue-derived stromal cells (ATSC) as alternatives to bone
marrow-derived stromal cells (BMSC) for bone repair has garnered interest due to the …

Orthopaedic tissues, such as bone, cartilage, intervertebral disc and tendon, contain cells
that are difficult to culture and stimulate in vitro for repair of damaged tissue. Stem cells have …

Stromal cells from bone marrow and adipose tissue are attractive sources of adult
progenitors for cell-based therapy. However, whether those cell populations represent …

Current cell-based repair strategies have proven unsuccessful for treating cartilage defects
and osteoarthritic lesions, consequently advances in innovative therapeutics are required …

Cartilage has only a very limited capacity to renew its original structure. Stem cells have
been used to repair damaged cartilage, and recent studies have indicated that stem cells …

The possibility of using adipose tissue‐derived stromal cells (ATSC) as alternatives to bone
marrow‐derived stromal cells (BMSC) for bone repair has garnered interest due to the …

Articular cartilage (AC) has limited potential for self‐regeneration and damage to AC
eventually leads to the development and progression of osteoarthritis (OA). Cell implantation …